1. Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. (10th April 2021) Authors: Funakoshi, Yusuke; Hata, Nobuhiro; Takigawa, Kosuke; Arita, Hideyuki; Kuga, Daisuke; Hatae, Ryusuke; Sangatsuda, Yuhei; Fujioka, Yutaka; Sako, Aki; Umehara, Toru; Yoshitake, Tadamasa; Togao, Osamu; Hiwatashi, Akio; Yoshimoto, Koji; Iwaki, Toru; Mizoguchi, Masahiro Journal: Cancer medicine Issue: Volume 10:Number 10(2021) Page Start: 3177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗